363 related articles for article (PubMed ID: 9049365)
1. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
Eloit M; Adam M
J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
[TBL] [Abstract][Full Text] [Related]
2. Replication-defective adenovirus type 5 as an in vitro and in vivo gene transfer vector in chickens.
Adam M; Oualikene W; Le Cocq H; Guittet M; Eloit M
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3153-7. PubMed ID: 8847523
[TBL] [Abstract][Full Text] [Related]
3. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.
Mittal SK; Papp Z; Tikoo SK; Baca-Estrada ME; Yoo D; Benko M; Babiuk LA
Virology; 1996 Aug; 222(2):299-309. PubMed ID: 8806514
[TBL] [Abstract][Full Text] [Related]
4. Lack of evidence of phenotypic complementation of E1A/E1B-deleted adenovirus type 5 upon superinfection by wild-type virus in the cotton rat.
Oualikene W; Gonin P; Eloit M
J Virol; 1995 Oct; 69(10):6518-24. PubMed ID: 7666553
[TBL] [Abstract][Full Text] [Related]
5. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine.
Eloit M; Gilardi-Hebenstreit P; Toma B; Perricaudet M
J Gen Virol; 1990 Oct; 71 ( Pt 10)():2425-31. PubMed ID: 2172456
[TBL] [Abstract][Full Text] [Related]
6. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration.
Fernández E; Toledo JR; Chiong M; Parra F; Rodríguez E; Montero C; Méndez L; Capucci L; Farnós O
Vet Immunol Immunopathol; 2011 Aug; 142(3-4):179-88. PubMed ID: 21621855
[TBL] [Abstract][Full Text] [Related]
7. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine.
Wu JQ; Barabé ND; Chau D; Wong C; Rayner GR; Hu WG; Nagata LP
Vaccine; 2007 May; 25(22):4368-75. PubMed ID: 17467858
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells.
Ambriović A; Adam M; Monteil M; Paulin D; Eloit M
Virology; 1997 Nov; 238(2):327-35. PubMed ID: 9400605
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in mice.
Gonin P; Oualikene W; Fournier A; Eloit M
Vaccine; 1996 Aug; 14(11):1083-7. PubMed ID: 8879106
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus E1a sequences relevant to the use of E1a- adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis.
Eissa NT; Chu CS; Danel C; Crystal RG
Hum Gene Ther; 1994 Sep; 5(9):1105-14. PubMed ID: 7833370
[TBL] [Abstract][Full Text] [Related]
11. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
12. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of pigs with replication-defective adenovirus vectored vaccines: the example of pseudorabies.
Adam M; Lepottier MF; Eloit M
Vet Microbiol; 1994 Nov; 42(2-3):205-15. PubMed ID: 7886933
[TBL] [Abstract][Full Text] [Related]
14. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W
J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816
[TBL] [Abstract][Full Text] [Related]
15. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
[TBL] [Abstract][Full Text] [Related]
16. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
17. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice.
Zsengeller ZK; Wert SE; Hull WM; Hu X; Yei S; Trapnell BC; Whitsett JA
Hum Gene Ther; 1995 Apr; 6(4):457-67. PubMed ID: 7612702
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the efficacy of a replication-defective adenovirus-vectored vaccine by the addition of oil adjuvants.
Ganne V; Eloit M; Laval A; Adam M; Trouve G
Vaccine; 1994 Oct; 12(13):1190-6. PubMed ID: 7839723
[TBL] [Abstract][Full Text] [Related]
19. Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species.
Oualikene W; Gonin P; Eloit M
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2765-8. PubMed ID: 7931164
[TBL] [Abstract][Full Text] [Related]
20. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
